ID

43588

Descripción

A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00371254

Link

https://clinicaltrials.gov/show/NCT00371254

Palabras clave

Versiones (2)
  1. 13/1/17 13/1/17 -
  2. 20/9/21 20/9/21 -
Subido en

20 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00371254

Inglés

Eligibility Breast Cancer NCT00371254

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
females, 18 or older
Descripción

Gender | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
recurrent or progressive locally advanced, or 'triple negative' metastatic breast cancer
Descripción

Breast cancer recurrent | Locally advanced breast cancer Progressive | Triple-Negative Breast Carcinoma metastatic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278493
UMLS CUI [2,1]
C3495949
UMLS CUI [2,2]
C0205329
UMLS CUI [3,1]
C3539878
UMLS CUI [3,2]
C1522484
paraffin-embedded tissue block must be available
Descripción

Paraffin Embedded Tissue Available

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1519524
UMLS CUI [1,2]
C0470187
measurable disease
Descripción

Measurable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
prior chemotherapy with an anthracycline, a taxane, or both (neoadjuvant, adjuvant, or metastatic setting)
Descripción

Neoadjuvant Chemotherapy | Chemotherapy, Adjuvant | Chemotherapy Neoplasm Metastasis | Anthracycline | taxane

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600558
UMLS CUI [1,2]
C0392920
UMLS CUI [2]
C0085533
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C0027627
UMLS CUI [4]
C0282564
UMLS CUI [5]
C0215136
0, 1 or 2 chemotherapies in the metastatic setting
Descripción

Chemotherapy Quantity Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
adequate organ function
Descripción

organ function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastatic disease confined to bone only
Descripción

Secondary malignant neoplasm of bone

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0153690
symptomatic cns metastasis
Descripción

CNS metastases Symptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0231220
concurrent medical condition which may increase the risk of toxicity
Descripción

Toxicity Risk Increased

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0035647
UMLS CUI [1,3]
C0442805
unable to take oral medication
Descripción

Oral medication administration Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001563
UMLS CUI [1,2]
C1299582
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00371254

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
females, 18 or older
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Breast cancer recurrent | Locally advanced breast cancer Progressive | Triple-Negative Breast Carcinoma metastatic
Item
recurrent or progressive locally advanced, or 'triple negative' metastatic breast cancer
boolean
C0278493 (UMLS CUI [1])
C3495949 (UMLS CUI [2,1])
C0205329 (UMLS CUI [2,2])
C3539878 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
Paraffin Embedded Tissue Available
Item
paraffin-embedded tissue block must be available
boolean
C1519524 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
Neoadjuvant Chemotherapy | Chemotherapy, Adjuvant | Chemotherapy Neoplasm Metastasis | Anthracycline | taxane
Item
prior chemotherapy with an anthracycline, a taxane, or both (neoadjuvant, adjuvant, or metastatic setting)
boolean
C0600558 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C0027627 (UMLS CUI [3,2])
C0282564 (UMLS CUI [4])
C0215136 (UMLS CUI [5])
Chemotherapy Quantity Neoplasm Metastasis
Item
0, 1 or 2 chemotherapies in the metastatic setting
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Secondary malignant neoplasm of bone
Item
metastatic disease confined to bone only
boolean
C0153690 (UMLS CUI [1])
CNS metastases Symptomatic
Item
symptomatic cns metastasis
boolean
C0686377 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Toxicity Risk Increased
Item
concurrent medical condition which may increase the risk of toxicity
boolean
C0600688 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0442805 (UMLS CUI [1,3])
Oral medication administration Unable
Item
unable to take oral medication
boolean
C0001563 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial